New Risk • Jul 16
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Paying a dividend despite having no free cash flows. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥51.43, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 38x in the Medical Equipment industry in China. Total returns to shareholders of 86% over the past three years. Announcement • Jul 01
Wuhan Huakang Century Clean Technology Co., Ltd. to Report First Half, 2026 Results on Aug 29, 2026 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 29, 2026 Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥73.63, the stock trades at a trailing P/E ratio of 59.4x. Average trailing P/E is 36x in the Medical Equipment industry in China. Total returns to shareholders of 132% over the past three years. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥61.01, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 41x in the Medical Equipment industry in China. Total returns to shareholders of 83% over the past three years. Declared Dividend • May 25
Dividend of CN¥0.20 announced Shareholders will receive a dividend of CN¥0.20. Ex-date: 29th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (16% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 19% per year over the past 4 years. However, payments have been volatile during that time. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • May 06
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥56.99, the stock trades at a trailing P/E ratio of 46x. Average trailing P/E is 39x in the Medical Equipment industry in China. Total returns to shareholders of 64% over the past three years. Reported Earnings • Apr 25
First quarter 2026 earnings released: CN¥0.16 loss per share (vs CN¥0.27 loss in 1Q 2025) First quarter 2026 results: CN¥0.16 loss per share (improved from CN¥0.27 loss in 1Q 2025). Revenue: CN¥405.5m (up 37% from 1Q 2025). Net loss: CN¥17.5m (loss narrowed 40% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Apr 25
Wuhan Huakang Century Clean Technology Co., Ltd., Annual General Meeting, May 15, 2026 Wuhan Huakang Century Clean Technology Co., Ltd., Annual General Meeting, May 15, 2026, at 14:30 China Standard Time. Location: 29F, Building 3, No. 718, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei China Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥49.30, the stock trades at a trailing P/E ratio of 47.5x. Average trailing P/E is 39x in the Medical Equipment industry in China. Total returns to shareholders of 40% over the past three years. Announcement • Mar 31
Wuhan Huakang Century Clean Technology Co., Ltd. to Report Q1, 2026 Results on Apr 25, 2026 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026 Valuation Update With 7 Day Price Move • Jan 16
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥48.22, the stock trades at a trailing P/E ratio of 46.5x. Average trailing P/E is 43x in the Medical Equipment industry in China. Total returns to shareholders of 25% over the past three years. Announcement • Dec 31
Wuhan Huakang Century Clean Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026 New Risk • Dec 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥42.06, the stock trades at a trailing P/E ratio of 40.5x. Average trailing P/E is 39x in the Medical Equipment industry in China. Total returns to shareholders of 13% over the past three years. Reported Earnings • Oct 25
Third quarter 2025 earnings released: EPS: CN¥1.02 (vs CN¥0.32 in 3Q 2024) Third quarter 2025 results: EPS: CN¥1.02 (up from CN¥0.32 in 3Q 2024). Revenue: CN¥596.6m (up 14% from 3Q 2024). Net income: CN¥42.5m (up 40% from 3Q 2024). Profit margin: 7.1% (up from 5.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year. Announcement • Sep 30
Wuhan Huakang Century Clean Technology Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥33.86, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 40x in the Medical Equipment industry in China. Total loss to shareholders of 11% over the past three years. New Risk • Jul 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Jul 30
Second quarter 2025 earnings released: EPS: CN¥0.53 (vs CN¥0.20 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.53 (up from CN¥0.20 in 2Q 2024). Revenue: CN¥539.6m (up 66% from 2Q 2024). Net income: CN¥47.6m (up 124% from 2Q 2024). Profit margin: 8.8% (up from 6.6% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Announcement • Jul 02
Wuhan Huakang Century Clean Technology Co., Ltd. to Report First Half, 2025 Results on Jul 30, 2025 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report first half, 2025 results on Jul 30, 2025 Declared Dividend • May 26
Dividend reduced to CN¥0.05 Dividend of CN¥0.05 is 50% lower than last year. Ex-date: 29th May 2025 Payment date: 29th May 2025 Dividend yield will be 0.2%, which is lower than the industry average of 2.2%. Payout Ratios Payout ratio: 8%. Cash payout ratio: 15%. Reported Earnings • Apr 25
First quarter 2025 earnings released: CN¥0.27 loss per share (vs CN¥0.30 loss in 1Q 2024) First quarter 2025 results: CN¥0.27 loss per share (improved from CN¥0.30 loss in 1Q 2024). Revenue: CN¥295.3m (up 28% from 1Q 2024). Net loss: CN¥29.0m (loss narrowed 9.7% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 12% per year. Announcement • Apr 25
Wuhan Huakang Century Clean Technology Co., Ltd., Annual General Meeting, May 16, 2025 Wuhan Huakang Century Clean Technology Co., Ltd., Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: 29F, Building 3, No. 718, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei China New Risk • Apr 07
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.4% net profit margin). Announcement • Mar 31
Wuhan Huakang Century Clean Technology Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Wuhan Huakang Century Clean Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Announcement • Dec 31
Wuhan Huakang Century Medical Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Wuhan Huakang Century Medical Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Announcement • Nov 27
Wuhan Huakang Century Medical Co., Ltd. (SZSE:301235) announces an Equity Buyback for CNY 70 million worth of its shares. Wuhan Huakang Century Medical Co., Ltd. (SZSE:301235) announces a share repurchase program. Under the program, the company will repurchase up to CNY 70 million worth of its shares. The repurchase price will not more than CNY 28 per Share. The repurchased shares will be used for employee stock ownership plan or equity incentives. The repurchases will be funded using company's own funds and self-raised funds (including repurchase special loan funds). The program is subject to shareholder's approval. The repurchase period will be not more than 12 months from the date on which the company's general meeting of shareholders reviews and approves the repurchase plan. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.35 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.32 (down from CN¥0.35 in 3Q 2023). Revenue: CN¥525.7m (up 16% from 3Q 2023). Net income: CN¥30.4m (down 17% from 3Q 2023). Profit margin: 5.8% (down from 8.1% in 3Q 2023). New Risk • Oct 09
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥19.65, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 31x in the Medical Equipment industry in China. Total loss to shareholders of 28% over the past year. Announcement • Sep 30
Wuhan Huakang Century Medical Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Wuhan Huakang Century Medical Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 12
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 7.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (5.0% net profit margin). Announcement • Jun 29
Wuhan Huakang Century Medical Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Wuhan Huakang Century Medical Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Announcement • May 25
Wuhan Huakang Century Medical Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 30 May 2024 Wuhan Huakang Century Medical Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.0000000 on A shares for the year 2023. Record date is 29 May 2024. Ex-date is 30 May 2024. Payment date is 30 May 2024. Announcement • Apr 29
Wuhan Huakang Century Medical Co., Ltd., Annual General Meeting, May 21, 2024 Wuhan Huakang Century Medical Co., Ltd., Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Wuhan, Hubei China Reported Earnings • Apr 27
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥1.02 (up from CN¥0.99 in FY 2022). Revenue: CN¥1.60b (up 35% from FY 2022). Net income: CN¥107.3m (up 4.7% from FY 2022). Profit margin: 6.7% (down from 8.6% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 39% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Medical Equipment industry in China. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥17.58, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 20x in the Medical Equipment industry in China. Total loss to shareholders of 50% over the past year. Announcement • Mar 30
Wuhan Huakang Century Medical Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Wuhan Huakang Century Medical Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥25.40, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Medical Equipment industry in China. Total loss to shareholders of 27% over the past year. New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (70% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change). Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥18.63, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Medical Equipment industry in China. Total loss to shareholders of 51% over the past year. Announcement • Dec 29
Wuhan Huakang Century Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Wuhan Huakang Century Medical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 Board Change • Dec 22
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 4 experienced directors. No highly experienced directors. Independent Director Liang Yu is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.35 (vs CN¥0.40 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.35 (down from CN¥0.40 in 3Q 2022). Revenue: CN¥452.1m (up 18% from 3Q 2022). Net income: CN¥36.7m (down 7.4% from 3Q 2022). Profit margin: 8.1% (down from 10% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Medical Equipment industry in China. Announcement • Oct 01
Wuhan Huakang Century Medical Co., Ltd. to Report Q3, 2023 Results on Oct 30, 2023 Wuhan Huakang Century Medical Co., Ltd. announced that they will report Q3, 2023 results on Oct 30, 2023 Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥0.22 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.39 (up from CN¥0.22 in 2Q 2022). Revenue: CN¥452.8m (up 71% from 2Q 2022). Net income: CN¥40.7m (up 61% from 2Q 2022). Profit margin: 9.0% (in line with 2Q 2022). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Medical Equipment industry in China. New Risk • Aug 18
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (59% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥24.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 22x in the Medical Equipment industry in China. Total loss to shareholders of 42% over the past year. Announcement • Jun 14
Wuhan Huakang Century Medical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 20, 2023 Wuhan Huakang Century Medical Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.30000000 on A shares for the year 2022. Record date is June 19, 2023. Ex-date is May June 20, 2023. Payment date is June 20, 2023. Announcement • May 19
Wuhan Huakang Century Medical Co., Ltd. Approves Cash Dividend for 2022 Wuhan Huakang Century Medical Co., Ltd. announced that at its AGM held on 16 May 2023, the shareholders approved 2022 profit distribution plan as cash dividend/10 shares (tax included): CNY 1.30000000. Reported Earnings • Apr 26
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.99. Revenue: CN¥1.19b (up 38% from FY 2021). Net income: CN¥102.5m (up 26% from FY 2021). Profit margin: 8.6% (in line with FY 2021). Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Medical Equipment industry in China. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥43.90, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 24x in the Medical Equipment industry in China. Board Change • Dec 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Yongwei Tan was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Nov 23
Wuhan Huakang Century Medical Co., Ltd. Announces Executive Appointments Wuhan Huakang Century Medical Co., Ltd. at the Extraordinary General Meeting of 2022 on 21 November 2022, approved election and nomination of non-independent directors, cumulative voting system applicable: Xie Xinqiang and Tan Yongwei; Election and nomination of independent directors, cumulative voting system applicable: Yu Liang, Guo Menghuan and Qi Liang; Election and nomination of non-employee supervisors, cumulative voting system applicable: Cheng Wenjie and Zhou Chenglin. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Director Changying Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.30 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.40 (up from CN¥0.30 in 3Q 2021). Revenue: CN¥383.2m (up 98% from 3Q 2021). Net income: CN¥39.6m (up 63% from 3Q 2021). Profit margin: 10% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Medical Equipment industry in China. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥38.12, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 22x in the Medical Equipment industry in China. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥44.20, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 25x in the Medical Equipment industry in China. Announcement • May 13
Wuhan Huakang Century Medical Co., Ltd. Announces Cash Dividend for the Year 2021, Payable on May 18, 2022 Wuhan Huakang Century Medical Co., Ltd. announced cash dividend/10 shares (tax included) of CNY 1.00000000 on A shares for the year 2021. Record date is 17 May 2022. Ex-date is 18 May 2022. Payment date is 18 May 2022. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment deteriorated over the past week After last week's 25% share price decline to CN¥33.00, the stock trades at a trailing P/E ratio of 42.8x. Average trailing P/E is 27x in the Medical Equipment industry in China. Announcement • Apr 10
Wuhan Huakang Century Medical Co., Ltd., Annual General Meeting, Apr 27, 2022 Wuhan Huakang Century Medical Co., Ltd., Annual General Meeting, Apr 27, 2022, at 14:30 China Standard Time. Agenda: To consider the 2021 annual report and its summary; to consider the 2021 work report of the board of directors; to consider the 2021 work report of the supervisory committee; to consider the2021 annual accounts; to consider the 2021 profit distribution plan; to consider the 2022 remuneration plan for directors; and to consider the 2022 remuneration plan for supervisors. Reported Earnings • Apr 10
Full year 2021 earnings released: EPS: CN¥1.03 (vs CN¥0.66 in FY 2020) Full year 2021 results: EPS: CN¥1.03 (up from CN¥0.66 in FY 2020). Revenue: CN¥860.8m (up 13% from FY 2020). Net income: CN¥81.4m (up 55% from FY 2020). Profit margin: 9.5% (up from 6.9% in FY 2020). The increase in margin was driven by higher revenue. Announcement • Apr 08
Wuhan Huakang Century Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2021 Wuhan Huakang Century Medical Co., Ltd. proposed final cash dividend of CNY 1.00000000 per ten shares (tax included) for the year 2021. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥58.50, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 33x in the Medical Equipment industry in China. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥39.20, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 35x in the Medical Equipment industry in China.